Lupin and SteinCares enter into License and Supply Agreement for Ranibizumab in Latin America
SteinCares will handle all regulatory filings, registrations and commercialisation of Ranibizumab in LATAM, while Lupin will be…
Sign in
Sign in
Recover your password.
A password will be e-mailed to you.
Browsing Tag
age-related macular degeneration
FDA approves Genentech’s Vabysmo Prefilled Syringe (PFS) for three leading causes of vision loss
Vabysmo PFS is reportedly the first and only syringe prefilled with an FDA-approved bispecific antibody to treat retinal…
Age-related macular degeneration market across 7MM set to reach $27.5 bn in 2031: GlobalData
Therapies with longer treatment intervals are a dominant trend in the AMD pipeline
Boehringer Ingelheim and CDR-Life to develop Antibody Fragment-based Therapeutics for Geographic…
The collaboration with CDR-Life is the second strategic partnership within a year for Boehringer Ingelheim in retinal diseases,…